[Gastroesophageal reflux disease: therapeutic features (Part II)].
Gastroesophageal reflux disease (GERD) can be defined as a condition resulting from the reflux of stomach contents into the esophagus. Its pharmacological treatment is aimed at symptom relief, healing of erosions and ulcerations and prevention of relapses. Based on the pathophysiology, the ideal treatment is directed to enhance basal sphincter pressure or decrease the frequency of TLESR, restore esophageal "clearance", accelerate gastric emptying and highten mucosal resistance as well as reduce or inhibit gastric acid secretion. Most of these targets are currently achievable because the availability of different types of drugs, however the "ideal" pharmacologic treatment of GERD does not exist. Current remedies for GERD include life style changes along with a wide array of antisecretory drugs, such as antacids, H2-antagonists and proton pump inhibitors (PPI). Surgery, based on anti-reflux procedures, and endoscopic approaches may have a role in the management of patients with GERD.
Corinaldesi
R
R
Dipartimento di Medicina Interna e Gastroenterologia, Università degli Studi di Bologna, Italia. robecori@med.unibo.it
Salvioli
B
B
Lioce
A
A
Barbara
G
G
Cremon
C
C
Fustini
E
E
Bini
L
L
Cogliandro
R
R
Boschi
E
E
Felicani
C
C
Stanghellini
V
V
De Giorgio
R
R
D005764:Gastroesophageal Reflux / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans